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ABSTRACT
As antibiotic resistance becomes an increasingly prominent issue in today’s medical reality, the
discovery of new bioactive compounds is quintessential to the vitality of tomorrow’s
generations. Fortunately the natural world has an almost limitless combination of compounds
that organisms can produce and modify to survive that have yet to be researched. This untapped,
continuously evolving database, has the potential to help abate the mounting resistance. This
study uses microbes as a product source with the goal of extracting and identifying antibiotic and
anticancer compounds. These microbes were derived from soil samples collected at the
archeological dig site in Pollentia, on the island of Mallorca, Spain. Over a hundred different
microbes were isolated initially by their morphology and antibiotic properties; three are focused
on for the purposes of this study. Extracts were tested against both gram positive Strep
epidermidis ATCC 1228, Staph aureus ATCC 25923, gram negative Escherichia coli DHIOB
Life Technologies and Pythium Ultimum provided by Gary Strobel from Montana State
University using the Agar disk diffusion and broth dilution methods (Balouiri 2016, Bauer
1966). Each bacteria affected a different combination of tests and further research needs to be
done to determine the molecules responsible for these results and identify of the microbial
species present.
INTRODUCTION
New anticancer and antibiotic compounds are in high demand due to the innumerable illnesses
that rely on them for treatment. Natural product research, unofficially or through modern
medicine has long been the answer to these ailments. Even now, much research is inspired by the
stories of ancient remedies; relying on the past to open the door to the modern age of medicine.

Before the advent of antibiotics in 1926 (Demain 2014), most routine surgeries, illnesses and
open wounds presented a risk of an infection that could have fatal consequences (Harvard 2014).
As the amount of antibiotic resistance cases escalates and the number of new antibiotics
approved by the FDA decreases each year (Demain 2014), the return to that life is an
increasingly probable reality. Reports on the subject, like the World Health Organization’s report
in 2015, forecast that antibiotic resistance will become widespread. These reports focus more on
tactics to delay that eventuality as well as to spearhead an action plan to counter it. Efforts to
reduce nonessential use and the prevention of improper use of antibiotics are vital in the solution
(Harvard 2014, WHO 2015). This includes the need to optimize not just human use, but also that
of agriculture and farming, where overuse leads to a leeching of antibiotics into the soil biomes
and ground water stores, increases the rates of resistance (W.H.O. 2015). Unlike anticancer
research, antibiotics research needs to compete with its own success to ensure the health of future
populations.
Not all antibiotics are meant to stop the growth of bacteria, or viruses. Some of the first
anticancer compounds were discovered not by a large research lab, but through the perseverance
of Dr. Monroe E. Wall and Dr. Mansukh C. Wani (Oberlies 2004). After working in the United
States department of Agriculture (USDA) extracting various plant compounds, Wall was inspired
by a query from a National Cancer Institute (NCI) researcher to test the samples for anticancer
activity (Oberlies 2004). The first attempt would not continue very long due to opposition by
USDA. Wall would move to the Research Triangle Institute (RTI) to form a natural products
laboratory supported by the NCI in 1960 (Oberlies 2004). He would eventually discover
Camptotheca acuminata’s active anticancer and antitumor component camptothecin in 1966
(Oberlies 2004). Wani was also in the same laboratory, joining in 1962 and both Wall and Wani

would go on to be credited for the initial discovery of taxol, an antileukemic and anticancer
compound, from T. brevifolia bark in 1971 (Demain 2014, Oberlies 2004). The final
identification of the structure can be mostly attributed to Wani’s persistent X-Ray
crystallography work (Oberlies 2004). Together, Wall and Wani opened the doors to natural
products research in the modern day anticancer field.
Natural Products Research
Starting with the extraction of morphine from poppy seed pods by Friedrich Sertümer roughly
200 years ago, to the discovery of penicillin by the advent of a stray orange peel by Alexander
Fleming in 1928; natural product research as previously stated, is not a new concept (Li 2009,
Demain 2014). These secondary metabolites, or natural products as they are generally referred to
as, include a wide umbrella of categories classified as anything produced that is not essential for
basic life functions (Buchanan 2000). Sources could be anything, with plants as the original
focus, but exploration into the diverse environments microorganisms inhabit have produced other
positive results. Many of these sources were previously unfeasible to study, but with advances in
culturing techniques, even marine microorganisms have been accessed (König 1996, Sheridan
2012). Compounds may be antibiotic, anticancer, antiviral, pesticides or serve to relieve any
number of other ailments (Kirst 2010, Oberlies 2004, Wells 2011). Some of the major benefits of
natural product based drugs also have contributed to its waning popularity. The tructures of these
compounds are often bulkier and varied than synthetic drugs. This lends to more complex
interactions in biological systems, lower toxicity and fewer modifications to optimize
performance (Demain 2014, Sheridan 2012). This also leads to increased time periods for
identification and for the discovering of synthesis pathways (Koehn 2005). This, in addition to
the often difficult extraction of large quantities of active components and the lack of a guarantee

that the compounds extracted are undiscovered or active, has led many pharmaceutical
companies away from natural product research. (Sheridan 2012).
Natural Product Drug Production
As recently as the 1990’s, 80% of all drugs were related to natural product beginnings (Li 2009).
Natural products antibiotic research was a prevalent in every major pharmaceutical company, but
as more technological methods have been developed many departments have closed (Sheridan
2012). High through put screening, combinatorial chemistry, advances in molecular biology and
genomics have led to this decrease as they require less, funding and production time before
testing (Koehn 2005, Shu 1998). Specific pathways can be targeted with the knowledge of cell
structures so that only computed matches to the biological puzzle pieces are made (Koehn 2005).
As the funding from pharmaceutical companies shifted from supporting antibiotics to supporting
long term drugs and ones that are more expensive; antibiotic research decreased (Li 2009). This
decrease in funding along with shorter FDA approval time led researchers to pursue
modifications of existing drugs as opposed to the discovery of new chemical compounds. As
chemical procedures and instruments became more advanced, the bulk of antibiotic research
turned from natural products to synthetic (Koehn 2005, Li 2009, Sheridan 2012). Recently has
been less effective at producing new non-toxic antibiotics (Koehn 2005). Using genomic
sequencing to discover new compounds could lead to a bridge between the two current
approaches and provide access to nature’s database of solutions (Li 2009). Some companies like
Warp Drive Bio are investing in this gap (Sheridan 2012).

This Study
The ground is an excellent place to search for microbes to study. There are up to 10

bacterial

cells for every gram of soil, with 4·10 to 5·10 different species represented (Raynaud 2014).
This wealth of diversity is often staggering and so the actinomycetes family is usually focused on
in studies (Demain 2014, Devi 2013). Out of all the discovered active components derived from
microbes, 32% have come from this family of bacteria (Demain 2014). Natural products, or
derivatives of them make up around 78 % of antibiotics and 74 % of antitumor agents (Demain
2014).
The goal of this experiment is to discover, isolate and identify new antibiotic and anticancer
compounds from actinomycetes. Soil samples were collected from Pollentia, an archeological
site on the island of Mallorca, Spain. This location was selected in the hopes of discovering soil
bacteria strains that differ from modern day ones.
MATERIALS AND METHODS
Sample Collection
All procedures sensitive to microbial contamination were done using a SterilGRAD® III
Advanceo hood.
A collection of sixteen soil samples were extracted aseptically, each from unique locations
throughout the archeological dig site of Pollentia on the island of Mallorca, Spain. The three
used in this study were, 8, 9 and 15. Sample eight was extracted from a quarry location 30 cm
below ground level, sample nine was in grey soil near a tree, 7 cm below the surface and sample
fifteen was under a rock near by the entrance of the church Santa Anna, 6 cm below the surface
level (Figure 1, Figure 2, Figure 3). 0.2 g of soil was mixed with 10 mL of distilled water.

Nutrient Formulas
All solutions were sterilized using an autoclave solid cycle for 30 minutes. All measurements are
for one liter with 15 g of agar added when used for plates. Color system refers to that used in the
laboratory.
The red - 100 g of oatmeal were boiled in deionized water for 10 minutes. The liquid was
strained off with a cheese cloth and collected. A one to one dilution was made with deionized
water.
The orange- 1 g of peptone, 1 g yeast extract, 2 g casin, 5 g glucose, 5 g malt extract. Added 1 L
of deionized water.
The yellow- 100 g of rice were boiled in deionized water for 10 minutes. The liquid was strained
off with a cheese cloth. A one to one dilution was made with deionized water.
The green- 1000 g of soil were sieved through a U.S.A. Standard Testing Sieve 600 micron and
stirred over night with 2 L of 50mM NaOH. Mixture was filtered, centrifuged and a one to one
dilution was made with deionized water.
The blue- 5 g anhydrous MgSO4, 10 g potato starch, 1 g of casin, and 0.5 g dipotassium
phosphate. Added 1 L of deionized water.
The purple- 39 g of Difco™ Potato Dextrose Agar. Added 1 L of deionized water.
Bacteria Agar Plate Culturing
All procedures sensitive to microbial contamination were done using a SterilGRAD® III
Advanceo hood. Agar was sterilized using an autoclave solid cycle for 30 min. All instruments
were sterilized using flames.

1 mL of the prepared soil sample was added to the various agar plates. Bacteria were allowed to
grow for several days to a week. Species were isolated based on whether they displayed
antibiotic traits, morphologies similar to those of actinomycetes, or general features of interest.
Strains were cultured on the same agar medium they were isolated from and the plates were
sealed with parafilm.
Bacteria Broth Culturing
All procedures sensitive to microbial contamination were done using a SterilGRAD® III
Advanceo hood. Broths were sterilized using an autoclave solid cycle for 30 min. All instruments
were sterilized using flames.
Broth solutions with the same nutrient profiles as the bacteria were cultured on, were used for the
liquid cultures. Over three to four weeks, the bacteria were grown in 500 mL flasks filled with
250 mL of broth on a shaker table with enough mature bacteria colonies introduced initially to
grow promptly (Figure 4). Exact shaking times were determined experimentally for each bacteria
by monitoring the activity and amount of crude product collected.
Isolation of Secondary Metabolites
Procedures with volatile chemicals were done under a HAMILTON ® SAFEAIRE® hood.
Weights were collected on an analytical scale.
The broth samples were rinsed three times with a total of 250 mL of dichloromethane in a
separatory funnel. The nonpolar layer was poured off after each rinse. Water based derivatives
were disposed of and the dichloromethane solution was dried with anhydrous ammonium sulfate.
Dichloromethane was distilled out using a rotavapor machine. Products were removed and
weighed using methanol, ethyl acetate, or hexane to dissolve.

Agar Plate Testing
All procedures sensitive to microbial contamination were done using a SterilGRAD® III
Advanceo hood. Agar was sterilized using an autoclave solid cycle for 30min. All instruments
were sterilized using flames.
Extracts were tested against S. epidermidis ATCC 1228, S. aureus ATCC 25923, and E. coli
DHIOB Life Technologies using the Kirby-Bauer method (Balouiri 2016, Bauer 1966), and
incubated at 37 C° for 24 hours (Figure 5). Paper disks were prepared with and 5 μL of product
extract, 3 μL of the antibiotic control Ampicillin and 5 μL of the solvent control(s). The
inhibition zones were measured and recorded for the induvial extracts.
Liquid Assay Testing
All procedures sensitive to microbial contamination were done using a SterilGRAD® III
Advanceo hood. Agar was sterilized using an autoclave solid cycle for 30min. All instruments
were sterilized using flames.
The broth dilution method with Pythium Ultimum provided by Gary Strobel from Montana State
University was used to test for anticancer properties (Balouiri 2016). Wells were filled 1 mL of
potato broth, a plug of P. Ultimum, and 5 μL of extract, or solvent control (Figure 6). Plates were
analyzed for inhibition every 24 hrs and kept at 22 C° for five days.
Thin Layer Chromatography (TLC)
Silica plates were prepared with 1- 3 μL and run using a 7:1 solution of chloroform and
methanol. Plates were analyzed under 254 nm and 365nm UV light and after the application of
an 18M sulfuric acid and vanillin solution (Figure 7).

Flash Chromatography
Crude products from multiple flasks of the same microbes were dissolved with methanol, ethyl
acetate and hexane then combined with 2-3 grams of silica gel 60 with a particle size of 0.0630.200 mm then dried for a minimum of 24 hours. A REVELERIS ™ flash chromatograph
system was run with a GRACE 4mg- 0.8 g 300 psi column. Hexane, ethyl acetate, and methanol
were used as solvents in order of increasing polarity. Concentrations were held at sites that
displayed multiple components. Fractions were combined according to peak groupings on the
chromatogram. Fraction extracts were retested according to the previously stated methods.
DNA Isolation
Bacteria were cultured in a liquid LB nutrient broth and incubated on a shaker table until mature
colonies formed. These were used in conjunction with a PowerSoil DNA Isolation Kit © to
separate the DNA. The DNA was frozen at -20 C°.
RESULTS
The goal of this project is to identify antibiotic and anticancer products from soil bacteria.
Figures 1-3 show where the bacteria was found.

Figure 1. This is location 8, at the top of a quarry 30 cm down, 30 over and 1 meter from the
edge (Hoffman 2016).

Figure 2. This is location 9, with the soil sample coming from above the quarry 8 cm down, 30
cm from the tree over and 15cm from the edge (Hoffman 2016).

Figure 3. This is location 15. The soil was taken from behind the Santa Anna Church under a
seemingly undisturbed stone, 6 cm below the surface (Hoffman 2016).

Figures 4-6 show various steps in the procedure to identify active compounds.

Figure 4. This collection of pictures contains the three bacteria studied, R9-2e, B8-2h and Y151a, in left to right order on the initial plate they were isolated from. Their colony appearance in a
broth culture is to the right of each bacteria.

Figure 5. These are the results of the initial Kirby-Bauer tests with S. epidermidis ATCC 1228,
S. aureus ATCC 25923, and E. coli DHIOB Life Technologies.

Figure 6. This is the initial liquid assay test with Pythium Ultimum provided by Gary Strobel
from Montana State University.

Figures 7-10 show analysis of the extracted compounds

Figure 7. This is an example of the three different analytic techniques applied to the TLC plates.
Plates were processed right to left with 254 nm and 365 nm UV light and an application 18M
sulfuric acid solution with vanillin.

Figure 8. R9-2e’s chromatogram shows multiple compounds at 12 CV and about 50:50 hexane
and ethyl acetate, with another grouping at 40CV 40:60 ethyl acetate and methanol and a group
at 60 CV with methanol as the solvent.

Figure 9. The chromatogram of B8-2h has most of its products congregated around 10 minutes
with 50:50 ethyl acetate and methanol and has two minor readings in the non-polar region.

Figure 10. The chromatogram of Y15-1a has many distinct groups. Major sites are at 1 minutes
with hexane as the carrier, 5 min 30:70 hexane to ethyl acetate and at 15 minutes with a 40:60
mixture of ethyl acetate and methanol.

DISCUSSION
As mentioned previously, the process of collecting natural product compounds can be a lengthy
one. The genes responsible for certain properties, do not always continue to be activate. It is
estimated that only 10% of the compounds that bacteria are capable of producing are observable
in a laboratory setting (Sheridan 2012).
Developing processes to ensure the consistent accumulation of product has occupied much of the
resources in this research. Finding the optimal time for liquid culture growth in order to
maximize product accumulation and account for the adjustments that need to be made to
accommodate the age and amount of starting colonies added, has been challenging. In addition
maintaining the bacteria colonies purity and activity after the initial isolation of the bacteria, has
proved difficult. The addition of Parafilm® around the growth plates, has aided in contamination
prevention. To combat changing metabolite production, purposeful contamination of older replated colonies and then subsequent isolation helped.
Before the extracts of a specific bacteria were combined for flash chromatography, a TLC was
done to confirm that there were similarities between them. Besides the initial S. epidermidis, S.
aureus, E. coli and Pythium Ultimum testing, bacterial extracts separated by flash
chromatography were not assayed on all cultures. Only the ones that the original extracts had
previously shown activity on were tested to prevent unnecessary product loss. The results of the
separation of each of the crude products is shown in Figures 8, 9 and 10. Initial test results of
these fractions show promising findings. R9-2e’s 2, 3, 4, 5, 6, 15 and 17, with unknown activity
of fractions 7-14, have strong activity against E. Coli. B8-2h’s 1, 4, 5, 12, 13 and 14 show
activity against S. epidermidis and fractions 4, 5, 8, 9, 10, 11, 14 have activity against S. aureus.
Y15-1a’s factions have yet to be processed.

CONCLUSION
These three bacteria produce multiple types of antibiotic and anti-cancer compounds. The
fractioned products of R9-2e and B8-2h showed promising results for antibiotic properties in
their S. aureus., S. epidermidis and E. coli. assays. Adjustment of the sample concentrations is in
the future will help identify the lowest effective concentration. The separations of the B8-2h, R92e, and Y15-1a’s crude products have led to greater confidence in the quantity of compounds to
investigate further. Production and collection of the active fractions for repeated separation is
needed for individual compound identification. Consistent production of the crude products is
still in progress. Identification of the bacteria species present by way of a national database will
be pursed in future research.
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